Xvivo Perfusion AB (publ) (0RKL.L) LSE

184.24

-1.0639(-0.57%)

Updated at December 23 05:09PM

Currency In SEK

Valuation

Market Cap15.4B
Enterprise Value15.02B
P/E Ratio193.73
PEG Ratio-2.66
Price/Sales Ratio7.12
Price/Book Ratio2.77
Enterprise/Revenue6.93
Enterprise/EBITDA55.58

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.04
Operating Margin0.08

Management Effectiveness

Return On Assets0.01
Return On Equity0.01

Income Statement

Revenue822.42M
Revenue/Share25.83
Gross Profit616.42M
EBITDA272.97M
Net Income172.18M
Diluted EPS5.44

Balance Sheet

Total Cash279.94M
Total Cash/Share8.89
Total Debt124.53M
Total Debt/Equity0.06
Current Ratio5.41
Book Value Per Share66.47

Price History

52-Week Change-61.67
52-Week High343.52
52-Week Low182.7
Moving Average 50 Days291.55
Moving Average 200 Days282.98

Statistics

Average Volume9,843
Shares Outstanding31.5M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A